EHR

Oxford BioTherapeutics’ Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3 

First patients dosed with BI 3820768 (OB33), marking third programme from the Oxford BioTherapeutics (OBT)-Boehringer Ingelheim collaboration to enter clinical...

Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers

Boehringer headquarters Boehringer headquarters, Ingelheim, Germany Boehringer Ingelheim is committed to improving outcomes for people facing aggressive cancers where there...

Black Book Study Finds Europe is Connected, But Not Yet Interoperable: Only 13% of Healthcare IT Users Say Vendors are EHDS-Ready

Following the Brussels EHDS interoperability meeting, Black Book's Q2 vendor-agnostic survey identifies Europe's EHDS-ready countries and vendors, and where real-world...

Trella Health Launches Physician Group Explore & Analyze to Help Post-Acute Organizations Identify High-Value Referral Opportunities

New Trella Insights feature helps home health, hospice, and skilled nursing organizations compare physician groups by patient volume, geography, specialty,...

Canadian Health IT Buyers Bring a Connected-Care Growth Agenda to e-Health26: Interoperability, Trusted Data and Measurable ROI

Black Book's 2026 Canada Digital Health Market Outlook finds a decisive shift from digitization to proof-driven procurement, with Canadian vendors...

Bridge Sets New Standard for Patient Intake, Scheduling, and Payment Platforms with Patient Access and Revenue Suite Launch

Enhanced Patient Access and Revenue Suite Strengthens Bridge's Unified Patient Engagement Platform to Eliminate Piecemealed Point Solutions and Deliver Market-Leading AutomationDALLAS,...

error: Content is protected !!